PMV Pharmaceuticals Ownership | Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals Ownership Summary

PMV Pharmaceuticals is owned by 23.40% institutional investors, 3.35% insiders, and 73.26% retail investors. Bml capital management is the largest institutional shareholder, holding 9.98% of PMVP shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.94% of its assets in PMV Pharmaceuticals shares.

PMVP Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PMV Pharmaceuticals	23.40%	3.35%	73.26%
Sector	Healthcare Stocks	35.49%	11.75%	52.76%
Industry	Biotech Stocks	34.83%	11.71%	53.46%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Bml capital management	5.32M	9.98%	$6.60M
Tang capital management	4.25M	7.97%	$5.26M
Sio capital management	3.08M	5.77%	$3.81M
Arrowmark colorado	2.87M	5.39%	$3.56M
Euclidean capital	2.63M	4.93%	$3.26M
Eversept partners, lp	2.35M	4.41%	$2.91M
Acadian asset management	2.22M	4.16%	$2.75M
Vanguard group	2.17M	4.10%	$2.71M
Two sigma investments, lp	1.88M	3.54%	$2.34M
Adage capital partners gp	1.86M	3.49%	$2.31M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bml capital management	5.32M	4.24%	$6.60M
Euclidean capital	2.63M	0.83%	$3.26M
Sio capital management	3.08M	0.55%	$3.81M
Aldebaran capital	473.36K	0.45%	$586.97K
Stonepine capital management	708.10K	0.35%	$878.05K
Tang capital management	4.25M	0.27%	$5.26M
Verdad advisers, lp	180.16K	0.25%	$223.40K
Eversept partners, lp	2.35M	0.15%	$2.91M
Arrowmark colorado	2.87M	0.09%	$3.56M
Rangeley capital	66.85K	0.08%	$82.89K

Top Buyers

Holder	Shares	% Assets	Change
Eversept partners, lp	2.35M	0.15%	2.35M
Adage capital partners gp	1.86M	0.00%	1.86M
Two sigma investments, lp	1.88M	0.00%	1.18M
Morgan stanley	864.31K	0.00%	765.44K
Longaeva partners	552.03K	0.03%	552.03K

Top Sellers

Holder	Shares	% Assets	Change
Orbimed advisors	-	-	-4.98M
Pfm health sciences, lp	-	-	-3.30M
Alkeon capital management	-	-	-2.34M
Blackrock	1.16M	-	-1.95M
Bank of america corp /de/	340.39K	-	-1.03M

New Positions

Holder	Shares	% Assets	Change	Value
Eversept partners, lp	2.35M	0.15%	2.35M	$2.91M
Adage capital partners gp	1.86M	0.00%	1.86M	$2.31M
Longaeva partners	552.03K	0.03%	552.03K	$684.51K
Vanguard fiduciary trust	298.13K	0.00%	298.13K	$369.68K
Verdad advisers, lp	180.16K	0.25%	180.16K	$223.40K

Sold Out

Holder	Change
Sbi securities	-1.00
Nelson, van denburg & campbell wealth management group	-8.00
Nisa investment advisors	-105.00
Raymond james financial	-200.00
Avion wealth	-299.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	29	-53.97%	12,465,938	-66.69%	23	0.47%	15	-53.13%	8	-52.94%
Dec 31, 2025	28	-55.56%	14,874,571	-60.33%	28	0.54%	13	-61.76%	10	-33.33%
Sep 30, 2025	60	22.45%	37,409,485	11.18%	71	1.72%	31	93.75%	15	-21.05%
Jun 30, 2025	53	-5.36%	34,682,029	-7.07%	66	1.29%	19	90.00%	20	-35.48%
Mar 31, 2025	6	-91.67%	13,804,026	-64.57%	26	0.47%	2	-90.48%	1	-96.77%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard US Total Market Shares ETF	1.52M	2.94%	-
Vanguard Total Stock Mkt Idx Inv	1.49M	2.79%	-
ACAP Strategic A	1.15M	2.16%	-
Meridian Small Cap Growth Legacy	1.08M	2.02%	-167.19K
ArrowMark Small Cap Gro	1.08M	2.02%	-167.19K
SQUAD Aguja Opportunities I	570.00K	1.08%	-
Vanguard Institutional Extnd Mkt Idx Tr	454.06K	0.85%	44.15K
Bridgeway Ultra-Small Company	331.45K	0.62%	89.70K
BlackRock Advantage Small Cap Core Instl	280.44K	0.53%	-
Goldman Sachs Small Cp Val Insghts Instl	249.01K	0.48%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 23, 2025	ORBIMED ADVISORS LLC	-	Sell	$1.52M
Sep 10, 2025	ORBIMED ADVISORS LLC	-	Sell	$900.00K
Jul 01, 2025	Ticktin Robert	General Counsel & COO	Sell	$24.65K
Jul 01, 2025	Jalota Deepika	Chief Development Officer	Sell	$35.20K
Jul 01, 2025	Carulli Michael	Chief Financial Officer	Sell	$30.08K

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	1
2025 Q3	-	5
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-

PMVP Ownership FAQ

Who Owns PMV Pharmaceuticals?

PMV Pharmaceuticals shareholders are primarily institutional investors at 23.40%, followed by 3.35% insiders and 73.25% retail investors. The average institutional ownership in PMV Pharmaceuticals's industry, Biotech Stocks , is 34.83%, which PMV Pharmaceuticals falls below.

Who owns the most shares of PMV Pharmaceuticals?

PMV Pharmaceuticals’s largest shareholders are Bml capital management (5.32M shares, 9.98%), Tang capital management (4.25M shares, 7.97%), and Sio capital management (3.08M shares, 5.77%). Together, they hold 23.73% of PMV Pharmaceuticals’s total shares outstanding.

Does Blackrock own PMV Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of PMV Pharmaceuticals.

Who is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Bml capital management is PMV Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.24% of its assets in 5.32M PMV Pharmaceuticals shares, valued at 6.6M$.

Who is the top mutual fund holder of PMV Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of PMV Pharmaceuticals shares, with 2.94% of its total shares outstanding invested in 1.52M PMV Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools